Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Synovitis, Pigmented Villonodular”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Not applicableStudy completedNCT04955535
What this trial is testing

Screening of Specific Genes for Pigmented Villous Nodular Synovitis

Who this might be right for
Pigmented Villonodular Synovitis
Peking University Third Hospital 60
Early research (Phase 1)Ended earlyNCT02673736
What this trial is testing

PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor

Who this might be right for
Solid TumorsTenosynovial Giant Cell TumorSynovitis, Pigmented Villonodular
Plexxikon 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT04703322
What this trial is testing

Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

Who this might be right for
Tenosynovial Giant Cell Tumor
Daiichi Sankyo Co., Ltd. 9
Large-scale testing (Phase 3)Active Not RecruitingNCT05417789
What this trial is testing

Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)

Who this might be right for
TGCT
SynOx Therapeutics Limited 128
Not applicableStudy completedNCT04952896
What this trial is testing

Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease

Who this might be right for
Synovial DiseasesPigmented Villonodular SynovitisGout+1 more
Peking University Third Hospital 350
Testing effectiveness (Phase 2)Ended earlyNCT04938180
What this trial is testing

Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients

Who this might be right for
Tenosynovial Giant Cell TumorPigmented Villonodular SynovitisTGCT+1 more
AmMax Bio, Inc. 4
Testing effectiveness (Phase 2)Study completedNCT02471716
What this trial is testing

Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor

Who this might be right for
Pigmented Villonodular SynovitisTenosynovial Giant Cell Tumor
Five Prime Therapeutics, Inc. 66
Testing effectiveness (Phase 2)Study completedNCT01643850
What this trial is testing

MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)

Who this might be right for
Pigmented Villonodular SynovitisPVNSGiant Cell Tumor of the Tendon Sheath+3 more
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT04731675
What this trial is testing

An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee

Who this might be right for
Tenosynovial Giant Cell TumorPigmented Villonodular Synovitis (PVNS)
AmMax Bio, Inc. 11
Not applicableNot Yet RecruitingNCT07503821
What this trial is testing

Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis

Who this might be right for
Synovitis Villonodular
Nantes University Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03069469
What this trial is testing

Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

Who this might be right for
Advanced Malignant NeoplasmPigmented Villonodular SynovitisGiant Cell Tumor of Tendon Sheath+2 more
Deciphera Pharmaceuticals, LLC 120
Testing effectiveness (Phase 2)Study completedNCT05349643
What this trial is testing

Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

Who this might be right for
Pigmented Villonodular SynovitisTGCTTenosynovial Giant Cell Tumor
AmMax Bio, Inc. 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05059262
What this trial is testing

Study of Vimseltinib for Tenosynovial Giant Cell Tumor

Who this might be right for
Tenosynovial Giant Cell TumorPigmented Villonodular SynovitisGiant Cell Tumor of Tendon Sheath+2 more
Deciphera Pharmaceuticals, LLC 123
Early research (Phase 1)Study completedNCT03291288
What this trial is testing

Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)

Who this might be right for
Drug Interaction Potential
Daiichi Sankyo 32
Testing effectiveness (Phase 2)Study completedNCT01207492
What this trial is testing

Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor

Who this might be right for
Pigmented Villonodular SynovitisDiffuse-type Giant Cell TumorTenosynovial Giant Cell Tumor
Andrew J. Wagner, MD, PhD 17
Not applicableStudy completedNCT02948088
What this trial is testing

Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project

Who this might be right for
Giant Cell Tumors
Daiichi Sankyo 183
Testing effectiveness (Phase 2)Study completedNCT01261429
What this trial is testing

Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)

Who this might be right for
Pigmented Villonodular Synovitis
Centre Leon Berard 50
Large-scale testing (Phase 3)Study completedNCT02371369
What this trial is testing

Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)

Who this might be right for
Pigmented Villonodular SynovitisGiant Cell Tumors of the Tendon SheathTenosynovial Giant Cell Tumor
Daiichi Sankyo 120
Large-scale testing (Phase 3)Active Not RecruitingNCT05804045
What this trial is testing

Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)

Who this might be right for
Tenosynovial Giant Cell TumorPigmented Villonodular SynovitisGiant Cell Tumor of Tendon Sheath
Abbisko Therapeutics Co, Ltd 90